Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors Versus Metformin. Qiu M. Ann Intern Med 2022;175:W155.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Qiu M. Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors Versus Metformin. Ann Intern Med 2022;175:W155.
PMID: 36534992